Overseas Chinese Equities, Aequitas Research

Ming Lu

Overseas Chinese Equities

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>Short video continued to accumulate active users in China and the company’s light-version grew the most rapidly.</li>
<li>We believe the revenue growth rate will rise from 2Q23 and the company will have positive operating profit from 2024.</li>
<li>We set the price target at HK$103, which is 44% over the market price.</li>
</ul>


Short video continued to accumulate active users in China and the company’s light-version grew the most rapidly.
We believe the revenue growth rate will rise from 2Q23 and the company will have positive operating profit from 2024.
We set the price target at HK$103, which is 44% over the market price.


Kuaishou (1024 HK): Expanding Market, Will See Higher Growth and Profit

APAC IPOs & Placements, Aequitas Research

Ethan Aw

APAC IPOs & Placements

Equity Capital Markets

<ul>
<li>Wuxi Biologics Holdings is looking to raise up to US$513m by selling about 1.3% of <a href="https://www.smartkarma.com/entities/wuxi-apptec" target="_blank" data-smartkarma-citation="entities:23679:1" rel="noopener">Wuxi Biologics (2269 HK). </a>
</li>
<li>This is the company's 16th placement since it listed in June 2017. </li>
<li>In this note, we will discuss deal dynamics, past deal performance, and share the scores on our ECM framework.</li>
</ul>


Wuxi Biologics Holdings is looking to raise up to US$513m by selling about 1.3% of Wuxi Biologics (2269 HK). 

This is the company's 16th placement since it listed in June 2017. 
In this note, we will discuss deal dynamics, past deal performance, and share the scores on our ECM framework.


Wuxi Biologics Placement - Lesser Discount than Recent Deals but Still Looks Good

Pan-Asia Index Flows & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Pan-Asia Index Flows & Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Event-Driven

<ul>
<li>The <a href="https://www.smartkarma.com/entities/hang-seng-china-enterprises-index" target="_blank" data-smartkarma-citation="entities:22900:1" rel="noopener">Hang Seng China Enterprises Index (HSCEI INDEX)</a> is one of the most widely discussed indices in the Hang Seng Indices family.</li>
<li>The HSCEI serves as a benchmark to reflect the overall performance of "Mainland" Securities listed in Hong Kong.</li>
<li>In this insight, we take a brief look at the selection criteria and the historical price performance of past Rebalance Events.</li>
</ul>


The Hang Seng China Enterprises Index (HSCEI INDEX) is one of the most widely discussed indices in the Hang Seng Indices family.
The HSCEI serves as a benchmark to reflect the overall performance of "Mainland" Securities listed in Hong Kong.
In this insight, we take a brief look at the selection criteria and the historical price performance of past Rebalance Events.


Quiddity Primer for HSCEI Rebalance Events

<ul>
<li>The Chinese government may possibly buy minor shares in Alibaba and Tencent.</li>
<li>JD.com’s long-term competitor, Dangdang, opened a bookstore in JD.com's app.</li>
<li>In 2022, both Tencent Video Account's active user base and time on site reached 80% of We Chat.</li>
</ul>


The Chinese government may possibly buy minor shares in Alibaba and Tencent.
JD.com’s long-term competitor, Dangdang, opened a bookstore in JD.com's app.
In 2022, both Tencent Video Account's active user base and time on site reached 80% of We Chat.


China Internet Weekly (16Jan2023): Alibaba, Tencent, JD.com, ByteDance

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of January 13th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight flows for China Mobile, Simcere Pharmaceutical, Tencent, Geely Automobile.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of January 13th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight flows for China Mobile, Simcere Pharmaceutical, Tencent, Geely Automobile.


Hong Kong Connect Flows (Jan 13th): Tencent Profit Taking

China

Tencent Holdings Limited operates as an investment holding company. The Company, through its subsidiaries, provides Internet and mobile value-added services (VAS), online advertising, and e-commerce transactions. Tencent Holdings offers services to users worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tencent (700 HK)

Kuaishou (1024 HK): Expanding Market, Will See Higher Growth and Profit

Short video continued to accumulate active users in China and the company’s light-version grew the most rapidly. We believe the revenue growth rate...

Ming Lu

Wuxi Biologics Placement - Lesser Discount than Recent Deals but Still Looks Good

Wuxi Biologics Holdings is looking to raise up to US$513m by selling about 1.3% of Wuxi Biologics (2269 HK). This is the company's 16th placement...

Ethan Aw

Quiddity Primer for HSCEI Rebalance Events

We evaluated the price and volume performance of 172 past HSCEI Rebalance cases (ADDs and DELs) from September 2008 to December 2022. We believe...

Janaghan Jeyakumar, CFA

China Internet Weekly (16Jan2023): Alibaba, Tencent, JD.com, ByteDance

Central governmental media encourages non-state-owned companies. JD’s competitor, Dangdang, opens a bookstore on JD.com. Tencent Video Account's...

Ming Lu

Hong Kong Connect Flows (Jan 13th): Tencent Profit Taking

We analyzed southbound Hong Kong connect flows in the past week and highlight flows for China Mobile, Simcere Pharmaceutical, Tencent, Geely...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)